Publisher： Bentham Science Publishers
E-ISSN： 1875-533x|13|26|3227-3238
ISSN： 0929-8673
Source： Current Medicinal Chemistry, Vol.13, Iss.26, 2006-01, pp. : 3227-3238
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin
Current Pharmaceutical Design, Vol. 19, Iss. 27, 2013-08 ,pp. :
Access to resources
Recommend
Sevelamer: antiatherogenic and anti-inflammatory properties
Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. :
PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk
Current Pharmaceutical Design, Vol. 23, Iss. 6, 2017-03 ,pp. :
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 1, 2010-03 ,pp. :